Australia Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Australia Insulin Infusion Pumps Market Report is Segmented by Component (Pump Device, Infusion Set, and Reservoir) and End User (Hospitals/Clinics, Homecare Setting, and Others). The Report Offers Market Sizes and Forecasts for all the Above Segments in Terms of Value (USD).

Australia Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Australia Insulin Infusion Pump Market Size

Australia Insulin Infusion Pump Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 108.42 Million
Market Size (2030) USD 135.76 Million
CAGR (2025 - 2030) 4.60 %

Major Players

Australia Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Australia Insulin Infusion Pump Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Australia Insulin Infusion Pump Market Analysis

The Australia Insulin Infusion Pump Market size in terms of Greater Than-4.60 is expected to grow from USD 108.42 million in 2025 to USD 135.76 million by 2030, at a CAGR of greater than 4.6% during the forecast period (2025-2030).

The insulin infusion pump market in Australia is poised for significant growth, driven by the rising diabetic population and an increasing number of regulatory approvals for insulin pumps.

The prevalence of diabetes is particularly among older people, who often experience multiple comorbidities, making insulin infusion pumps an attractive option for their long-term care. The Australian Bureau of Statistics data, updated as of December 2023, revealed a diabetes prevalence of 37.8% among men and 27.7% among women over 65. Given that diabetes is more prevalent in this age group, the demand for insulin infusion pumps, crucial for precise insulin dosing, is expected to increase.

Government initiatives to alleviate the financial burden on patients relying on insulin pumps are further propelling market growth. In July 2023, the Australian government, in collaboration with key health organizations like the Australian Diabetes Educators Association (ADEA) and the Australian Diabetes Society (ADS), unveiled the Diabetes Australia Group Strategic Plan 2023-2027. This joint effort underscores their commitment to improving the quality of life for individuals with diabetes.

The 2024-25 Union Budget of Australia allocated an additional AUD 3.7 million (USD 2.5 million) to expand the Insulin Pump Program. This move specifically targets financially disadvantaged Australians under 21 with type 1 diabetes, aiming to make insulin infusion pumps more accessible. By expanding the affordability, this initiative is expected to benefit the low to middle-income groups, boosting pump adoption rates and market growth.

The combination of a growing diabetic population, particularly among older people, and supportive government initiatives is set to drive the expansion of the insulin infusion pump market in Australia. These factors collectively enhance the accessibility and adoption of insulin pumps, which is expected to boost market growth in the coming years.

Australia Insulin Infusion Pump Industry Overview

The Australian insulin infusion pump market is consolidated, with major manufacturers holding a global market presence and the remaining manufacturers confined to other local or region-specific manufacturers. The competitive landscape includes examining a few well-known worldwide and local organizations, such as Medtronic, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care.

Australia Insulin Infusion Pump Market Leaders

  1. Medtronics

  2. Ascensia Diabetes Care

  3. Insulet Corporation

  4. Tandem Diabetes Care

  5. Ypsomed

  6. *Disclaimer: Major Players sorted in no particular order
Australia Insulin Infusion Pump Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Australia Insulin Infusion Pump Market News

  • September 2023: Australia's Minister for Health and Aged Care, the Hon. Mark Butler MP, confirmed that Fiasp insulin will continue to be available under the Pharmaceutical Benefits Scheme (PBS) for diabetic individuals from October 2023.
  • July 2023: Dexcom Inc. and its Australian subsidiary, Australasian Medical and Scientific Ltd (AMSL Diabetes), reported that the Department of Veterans Affairs (DVA) would fully fund diabetes products. These include the Dexcom Continuous Glucose Monitoring (CGM) and Tandem t:slim X2 Insulin Pump systems, available to qualifying DVA clients.

Australia Insulin Infusion Pump Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Diabetes Prevalence in Australia
    • 4.2.2 Government Support Initiatives to Construct the Spread of Diabetes
  • 4.3 Market Restraints
    • 4.3.1 Limited Awareness About the Pump and Related-Technology
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size By Values - USD)

  • 5.1 By Component Type
    • 5.1.1 Insulin Pump Device
    • 5.1.2 Infusion Set
    • 5.1.3 Reservoir
  • 5.2 By End Users
    • 5.2.1 Hospitals/Clinics
    • 5.2.2 Home Care
    • 5.2.3 Others

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetic Population (2021-2029)
  • 6.2 Type-2 Diabetic Population (2021-2029)

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Medtronics
    • 7.1.2 Ascensia Diabetes Care
    • 7.1.3 Insulet Corporation
    • 7.1.4 Tandem Diabetes Care
    • 7.1.5 Ypsomed
  • *List Not Exhaustive

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Australia Insulin Infusion Pump Industry Segmentation

An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. 

The Australian insulin infusion pumps market is segmented by component. By component, the market is segmented into pump device, infusion set, and reservoir. The report offers the value (in USD) and volume (units) for all the above segments.

By Component Type Insulin Pump Device
Infusion Set
Reservoir
By End Users Hospitals/Clinics
Home Care
Others
Need A Different Region or Segment?
Customize Now

Australia Insulin Infusion Pump Market Research FAQs

How big is the Australia Insulin Infusion Pump Market?

The Australia Insulin Infusion Pump Market size is expected to reach USD 108.42 million in 2025 and grow at a CAGR of greater than 4.60% to reach USD 135.76 million by 2030.

What is the current Australia Insulin Infusion Pump Market size?

In 2025, the Australia Insulin Infusion Pump Market size is expected to reach USD 108.42 million.

Who are the key players in Australia Insulin Infusion Pump Market?

Medtronics, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomed are the major companies operating in the Australia Insulin Infusion Pump Market.

What years does this Australia Insulin Infusion Pump Market cover, and what was the market size in 2024?

In 2024, the Australia Insulin Infusion Pump Market size was estimated at USD 103.43 million. The report covers the Australia Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Australia Insulin Infusion Pump Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Australia Insulin Infusion Pump Industry Report

Statistics for the 2025 Australia Insulin Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Australia Insulin Infusion Pump analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.